| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.28% | 1.95% | -13.86% | -9.45% | -4.92% | 78 232 |
| REGENERON PHARMACEUTICALS, INC. | 0.90% | 3.61% | 3.13% | 24.36% | 111.44% | 69 552 |
 | WUXI APPTEC CO., LTD. | -2.06% | 1.36% | -16.67% | -22.60% | 185.12% | 43 023 |
| BIONTECH SE | -3.65% | 16.65% | -40.64% | -22.83% | --.--% | 38 601 |
 | GENMAB A/S | 3.74% | -14.83% | -19.81% | -10.48% | 83.31% | 18 636 |
 | ARGENX SE | 0.60% | 1.29% | -4.92% | 32.54% | 159.57% | 16 947 |
| BEIGENE, LTD. | -1.48% | -9.79% | -51.68% | -59.56% | -5.31% | 13 709 |
| NEUROCRINE BIOSCIENCES, INC. | 0.47% | 5.74% | -0.77% | -9.20% | 5.64% | 8 040 |
| EXELIXIS, INC. | 1.37% | -6.56% | 11.35% | -19.35% | 2.85% | 6 429 |
| LEGEND BIOTECH CORPORATION | 4.43% | 8.97% | -11.81% | 33.03% | --.--% | 6 070 |
| SAREPTA THERAPEUTICS, INC. | 2.15% | -5.97% | -25.16% | -10.30% | -45.04% | 5 772 |
| INTRA-CELLULAR THERAPIES, INC. | 0.08% | 27.92% | 13.01% | 59.43% | 375.48% | 5 575 |
| HALOZYME THERAPEUTICS, INC. | 3.67% | 3.01% | 4.22% | -1.21% | 163.22% | 5 569 |
 | BIOCON LIMITED | -1.92% | -6.28% | -12.27% | -17.72% | 20.58% | 5 008 |
| ASCENDIS PHARMA A/S | 0.81% | 0.05% | -37.72% | -38.22% | -31.82% | 4 638 |
| | | | | | | |
| | Gemiddelde | 0.63% | 1.81% | -13.57% | -4.77% | 78.47% | |
| | Gewogen gemiddelde per kap. | -0.06% | 2.70% | -14.13% | -4.17% | 79.24% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
